Anandamide Increased Both Morphine Antinociception and Tolerance in a Rat Study

Anandamide enhanced morphine antinociception in rats but also increased the reported expression of morphine tolerance. An immediate stronger drug effect therefore did not translate into less adaptation during the experimental regimen.

The design compared activation and blockade

Male rats underwent a cumulative morphine regimen to establish tolerance. Investigators compared the endogenous cannabinoid agonist anandamide and the CB1 antagonist rimonabant using tail-flick and hot-plate tests. These thermal responses are experimental antinociception endpoints, not a complete assessment of clinical pain.

The agonist findings required both qualifiers

Anandamide combined with morphine increased antinociception, while the same research reported increased tolerance expression. Reporting only stronger analgesia would omit a central adaptation result. Injected anandamide also differs from administering THC or increasing every endocannabinoid pathway equally.

The antagonist showed a different pattern

Rimonabant attenuated morphine tolerance under the tested conditions. The comparison supports a role for cannabinoid-system manipulation but does not establish that antagonist treatment is clinically preferable or safe. The paper's conclusion is bounded by the rat protocol, doses and time points.

The study highlights a useful distinction between improving an acute response and preserving that response over repeated exposure. It does not justify selecting a cannabis product for opioid tolerance or provide a human combination regimen. The direction of an interaction can depend on which outcome is measured.

Related: interpreting cannabis tolerance claims.

Research cited

Altun A; Ozdemir E; Yildirim K; Gursoy S; Durmus N; Bagcivan I. The effects of endocannabinoid receptor agonist anandamide and antagonist rimonabant on opioid analgesia and tolerance in rats. General physiology and biophysics (2015). doi:10.4149/gpb_2015017. Findings discussed from the study abstract.

Spread the love


The National Black Lawyers

top 40 lawyers

civil trial law

Lawyers of Distinction

Loading...

Recent Blog Articles

An Early CBD–THC Trial Changed Subjective Responses Without Changing the Pulse Response

An eight-person trial summarized in the review found that CBD altered selected subjective THC effects without changing the pulse-rate response. The distinction argues against describing the result as a general blockade of THC. The small crossover included several comparators Healthy volunteers received THC, CBD, a THC–CBD combination, placebo and diazepam…

Spread the love

Read Article: An Early CBD–THC Trial Changed Subjective Responses Without Changing the Pulse Response

Adding CBC or CBD Did Not Change Outcomes in a Small Smoked-Cannabis Experiment

A controlled cannabis experiment summarized in the review found no change in its outcome measures when selected amounts of CBC or CBD were added to THC-containing cigarettes. The result tests a particular interaction claim, rather than every proposed effect of those cannabinoids. The study varied cannabis composition The review describes…

Spread the love

Read Article: Adding CBC or CBD Did Not Change Outcomes in a Small Smoked-Cannabis Experiment

THC–CBD Sleep Findings Differed Between the Night and the Following Morning

A small crossover study summarized in the review did not find improved nocturnal sleep with THC alone, yet reported next-morning effects. THC–CBD combinations produced a different sleep pattern. Feeling sleepy afterward should not be substituted for evidence of better sleep overnight. The experiment compared several oromucosal treatments Eight participants received…

Spread the love

Read Article: THC–CBD Sleep Findings Differed Between the Night and the Following Morning

Speak with an expert today!

Contact the offices of Okorie Okorocha for professional and reliable advice which you can trust.

Call (424) 363-3347 Contact Us